Folgen
Eva Stadler
Eva Stadler
Bestätigte E-Mail-Adresse bei kirby.unsw.edu.au
Titel
Zitiert von
Zitiert von
Jahr
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ...
Nature Reviews Immunology 22 (6), 387-397, 2022
1092022
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ...
Immunity 55 (7), 1316-1326. e4, 2022
402022
Determinants of passive antibody efficacy in SARS-CoV-2 infection
E Stadler, KL Chai, TE Schlub, D Cromer, MN Polizzotto, SJ Kent, ...
medrxiv, 2022.03. 21.22272672, 2022
302022
Monoclonal antibody levels and protection from COVID-19
E Stadler, MT Burgess, TE Schlub, SR Khan, KL Chai, ZK McQuilten, ...
Nature Communications 14 (1), 4545, 2023
152023
Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure
S Mehra, E Stadler, D Khoury, JM McCaw, JA Flegg
Journal of Theoretical Biology 537, 111014, 2022
132022
Evolutionary Stability of Salmonella Competition with the Gut Microbiota: How the Environment Fosters Heterogeneity in Exploitative and Interference Competition
J Müller, S Spriewald, B Stecher, E Stadler, TM Fuchs
Journal of molecular biology, 2019
102019
Eigensolutions and spectral analysis of a model for vertical gene transfer of plasmids
E Stadler
Journal of Mathematical Biology 78 (5), 1299-1330, 2019
92019
Evolutionary Stabilization of Cooperative Toxin Production through a Bacterium-Plasmid-Phage Interplay
S Spriewald, E Stadler, BA Hense, PC Münch, AC McHardye, AS Weiss, ...
mBio 11, e00912-20, 2020
82020
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis
KM Elias, SR Khan, E Stadler, TE Schlub, D Cromer, MN Polizzotto, ...
medRxiv, 2023.06. 18.23291566, 2023
52023
Population heterogeneity in Plasmodium vivax relapse risk
E Stadler, D Cromer, S Mehra, AI Adekunle, JA Flegg, NM Anstey, ...
PLoS neglected tropical diseases 16 (12), e0010990, 2022
52022
Plasmid segregation and accumulation
J Müller, K Münch, B Koopmann, E Stadler, L Roselius, D Jahn, R Münch
arXiv preprint arXiv:1701.03448, 2017
52017
Analyzing plasmid segregation: existence and stability of the eigensolution in a non-compact case
E Stadler, J Müller
Discrete & Continuous Dynamical Systems-B, 2020
42020
Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection
M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ...
medRxiv, 2021.12. 23.21268285, 2021
32021
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
E Stadler, KL Chai, TE Schlub, D Cromer, SR Khan, MN Polizzotto, ...
The Lancet Microbe 4 (11), e883-e892, 2023
22023
Propensity of selecting mutant parasites for the antimalarial drug cabamiquine
E Stadler, M Maiga, L Friedrich, V Thathy, C Demarta-Gatsi, A Dara, ...
Nature communications 14 (1), 5205, 2023
22023
Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data
E Stadler, D Cromer, S Ogunlade, A Ongoiba, S Doumbo, K Kayentao, ...
Malaria Journal 22 (1), 42, 2023
22023
Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population
E Stadler, D Cromer, S Mehra, AI Adekunle, JA Flegg, NM Anstey, ...
medRxiv, 2022.05. 18.22275180, 2022
12022
A role for super-spreaders in carrying malaria parasites across the months-long dry season
E Stadler, D Cromer, S Ogunlade, A Ongoiba, S Doumbo, K Kayentao, ...
medRxiv, 2022.04. 28.22274398, 2022
2022
Determinants of passive antibody efficacy in SARS-CoV-2 infection (preprint)
E Stadler, KL Chai, T Schlub, D Cromer, M Polizzotto, S Kent, C Beecher, ...
2022
Monoclonal antibody levels and protection from COVID-19 (preprint)
E Stadler, MT Burgess, TE Schlub, KL Chai, ZK McQuilten, EM Wood, ...
2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20